Chloe Bloom is a NIHR Clinician Scientist and group leader at NHLI, working in the field of respiratory epidemiology. She is an Honorary Consultant in Respiratory Medicine at Imperial College Healthcare NHS Trust working in integrated respiratory care and specialist asthma clinics. Her teaching roles including Respiratory Lead for Imperial College Medical School years 5 & 6 and supervision of BSc and MSc students.
She read Medicine at the University of Manchester and graduated with Honours in Research and a BSc in Biological Sciences from Imperial College London. Chloe undertook specialist respiratory training in North West London and was awarded a MRC Clinical Research Training Fellow. She carried out her PhD at the MRC-National Institute for Medical Research under Professor Anne O'Garra FRS, applying bioinformatics and biostatistics to evaluate genomic and clinical data from respiratory patients. After receiving her CCT she obtained an MSc in Epidemiology from the London School of Hygiene and Tropical Medicine.
Chloe joined Imperial College London in 2017 on a NHLI fellowship. She was awarded a prestigious NIHR Advanced Fellowship in 2021 to lead a programme of research in asthma related to the use of asthma medication, involving quantitative and qualitative approaches and a data-driven pragmatic trial.
The research interests of her group are centered on the use of large clinical data to improve the management of respiratory disease, with a focus on adult and paediatric asthma, as well as other respiratory diseases including covid-19 and COPD.
Conway FM, Bloom CI, Shah PL, 2022, Susceptibility of patients with airways disease to SARS-CoV-2 infection., American Journal of Respiratory and Critical Care Medicine, Vol:206, ISSN:1073-449X, Pages:696-703
Stewart I, Bloom C, 2021, Considerations for conducting and interpreting long-term follow-up of intervention studies: avoiding spoiled milk, Thorax, Vol:76, ISSN:0040-6376, Pages:1067-1068
Bloom CI, Johnston SL, 2021, Decline in respiratory and cardiac admissions during the COVID-19 pandemic: what is the role of common respiratory virus infections?, Respirology, Vol:26, ISSN:1323-7799, Pages:1010-1011
Bloom CI, Cullinan P, Wedzicha JA, 2021, Asthma phenotypes and COVID-19 risk: a population-based observational study, American Journal of Respiratory and Critical Care Medicine, Vol:205, ISSN:1073-449X, Pages:36-45
et al., 2021, Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK, The Lancet Respiratory Medicine, Vol:9, ISSN:2213-2600, Pages:699-711
et al., 2021, Burden of preschool wheeze and progression to asthma in the UK: population-based cohort 2007 to 2017, Journal of Allergy and Clinical Immunology, Vol:147, ISSN:0091-6749, Pages:1949-1958
et al., 2020, Health and cost impact of stepping down asthma medication for UK patients, 2001–2017: a population-based observational study, PLOS Medicine, Vol:17, ISSN:1549-1277
et al., 2019, Cost saving of switching to equivalent inhalers and its effect on health outcomes, Thorax, Vol:74, ISSN:1468-3296, Pages:1078-1086
et al., 2019, Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population based cohort 2006 to 2016, European Respiratory Journal, Vol:53, ISSN:0903-1936, Pages:1-8
et al., 2018, Exacerbation patterns in adults with asthma in England: A population based study, American Journal of Respiratory and Critical Care Medicine, Vol:199, ISSN:1073-449X, Pages:446-453
et al., 2018, Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza, Nature Immunology, Vol:19, ISSN:1529-2916, Pages:625-635
et al., 2018, Exacerbation risk and characterisation of the UK’s asthma population, from infants to old age, Thorax, Vol:73, ISSN:1468-3296, Pages:313-320
et al., 2018, Low uptake of palliative care support for COPD patients within primary care in the UK, European Respiratory Journal, Vol:51, ISSN:0903-1936
et al., 2013, Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers, PLOS One, Vol:8, ISSN:1932-6203
et al., 2012, Detectable Changes in The Blood Transcriptome Are Present after Two Weeks of Antituberculosis Therapy, PLOS One, Vol:7, ISSN:1932-6203
et al., Characteristics of a large nationally representative UK primary care asthma population and their incidence and determinants of asthma exacerbations, American Thoracic Society